Evaluation of The Preventive Effects of Carvedilol on Trastuzumab-Induced Cardiotoxicity in Early-Stage and Locally Advanced HER2-Positive Breast Cancer Patients

International Journal of Hematology-Oncology and Stem Cell Research

Azadeh Sadat Naseri¹  Mohsen Esfandbod²  Mohammadtaghi Noroozi³  Mina Naderi⁴  Saeid Sadeghi Joni⁵  Ayat Ahmadi⁶ 

[1] Department of Cardiology, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran;Department of Clinical Hematology and Bone Marrow Transplantation, Vali-e-Asr Hospital, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran;Department of Internal Medicine, Medical Oncology-Hematology Ward,Sina Hospital, Tehran University of Medical Science (TUMS), tehran, iran;Department of Internal Medicine, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran;Department of Radiology, Razi Hospital, Guilan University of Medical Sciences, Rasht, Iran;Knowledge Utilization Research Center, Tehran University of Medical Sciences, Tehran, Iran;

关键词: Trastuzumab-induced cardiotoxicity;    Carvedilol;    Human epidermal growth factor receptor-2 (HER-2);    Ejection fraction;    Pulmonary artery pressure;   

DOI  :  10.18502/ijhoscr.v15i4.7475

来源: DOAJ

【 授权许可】

Unknown